# Roadmap & Milestone

NOTT’s roadmap encapsulates a multi-phased journey toward innovation and leadership in smart healthcare technology, with a focus on delivering revolutionary wellness solutions. This vision spans from foundational concepts to global industry leadership, guided by a commitment to research, technological integration, and sustainability.

{% stepper %}
{% step %}

### Phase 1: Project Kick-off (2019-2020)

* **Concept & Research (Q1 2019 - Q3 2019):** Conducted comprehensive market analysis and technical groundwork.
* **Team Building (Q4 2019):** Assembled interdisciplinary experts to lead hardware, software, and healthcare advancements.
* **Company Registration & Infrastructure Setup (Q1 2020):** Established the operational and physical foundation, setting the stage for R\&D.

{% endstep %}

{% step %}

### Phase 2: Research & Development (2020-2023) 

**Turning Concepts into Reality**

* **Prototype Development (Q2 2020 - Q1 2022):** Created functional prototypes for a suite of wellness products.
* **Software Development (Q2 2022 - Q4 2022):** Built innovative mobile platforms featuring real-time health monitoring.
* **System Integration & Testing (Q1 2023 - Q3 2023):** Performed rigorous evaluations to refine hardware-software synergy.
* **Final R\&D Milestone (Q4 2023):** Completed privacy protocols and product adjustments to prepare for testing phases.

{% endstep %}

{% step %}

### Phase 3: Testing & Medical Certification (2024-Present) 

**Achieving Safety and Compliance**

* **Pre-Clinical Testing (Q1 2024 - Q2 2024):** Validated initial device safety and performance through clinical simulations.
* **Medical Certification Process (Q3 2024 - Q2 2025):** Pursued global medical device certifications for regulatory compliance.
* **Field Trials & Pilot Deployments (Planned for Q3 2025):** Piloted products in real-world settings to collect actionable feedback.

{% endstep %}

{% step %}

### Phase 4: Production & Market Launch (Q3 2025 - Q4 2026) 

**Scaling for Global Impact**

* **Mass Production Setup (Q3 2025 - Q1 2026):** Partnered with manufacturers for large-scale production.
* **Product Finalization (Q1 2026 - Q2 2026):** Enhanced user readiness with detailed manuals and installation guides.
* **Marketing & Brand Awareness (Q2 2026 - Q3 2026):** Leveraged strategic marketing campaigns to build excitement.
* **Official Product Launch (Q4 2026):** Rolled out products globally, marking a milestone in healthcare innovation.

{% endstep %}

{% step %}

### Phase 5: Market Expansion & Customer Support (2027-2028) 

**Establishing a Global Presence**

* **Global Market Entry (Q1 2027 - Q4 2027):** Expanded to international markets, ensuring seamless logistics and service.
* **Service & Support Infrastructure (Q2 2027 - Q1 2028):** Launched robust customer service channels and AI-powered support tools.
* **Ecosystem Integration (Q2 2028 - Q4 2028):** Strengthened compatibility with major smart home platforms and healthcare networks.
* **Healthcare Partnerships & Insurance Integration (Q3 2028 - Q4 2028):** Offered innovative solutions backed by insurance and corporate wellness programs.

{% endstep %}

{% step %}

### Phase 6: Product Innovation & Upgrades (2029-2030)

**Shaping the Future of Wellness Technology**

* **Product Line Expansion (Q1 2029 - Q4 2029):** Introduced advanced product tiers with AI-driven health insights.
* **Next-Gen Tech Integration (Q1 2030 - Q3 2030):** Embraced cutting-edge technologies to enable predictive healthcare solutions.
* **Health Data Insights Platform (Q3 2030 - Q4 2030):** Launched a secure, subscription-based platform for personalized wellness insights.

{% endstep %}

{% step %}

### Phase 7: Industry Leadership & Sustainability (2031 and Beyond)

**Driving Innovation and Social Responsibility**

* **Research & Innovation Center (Q1 2031 - Q4 2031):** Established a hub for groundbreaking R\&D collaborations.
* **Sustainability & ESG Initiatives (Q2 2031 - Q4 2032):** Committed to eco-friendly materials and recycling programs.
* **Corporate Social Responsibility (Q1 2032 - Ongoing):** Supported underserved communities through product donations and research sponsorships.
* **Global Industry Leadership (2032+):** Cemented NOTT’s role as a leader in smart healthcare technology through continuous evolution and advocacy.
  {% endstep %}
  {% endstepper %}